Pstein-Barr viral DNA in lymphoblastoid cell lines induced by transfection with
Pstein-Barr viral DNA in lymphoblastoid cell lines induced by transfection with BZLF1. Virology 1993, 194(2):83842. five. Cho MS, Chan SY: Vectors obtaining terminal repeat sequence of Epstein-Barr virus. In US Patent 6180108. Washington, DC: U.S. Patent and Trademark Workplace; 2001. six. Sun R, Spain TA, Lin SF, Miller G: Autoantigenic proteins that bind recombinogenic sequences in Epstein-Barr virus and cellular DNA. Proc Natl Acad Sci U S A 1994, 91(18):8646650. 7. Matsuo T, Heller M, Petti L, OShiro E, Kieff E: Persistence in the entire Epstein-Barr virus Topoisomerase medchemexpress genome integrated into human lymphocyte DNA. Science 1984, 226(4680):1322325. eight. Leenman EE, Panzer-Grumayer RE, Fischer S, Leitch HA, Horsman DE, Lion T, Gadner H, Ambros PF, Lestou VS: Rapid determination of Epstein-Barr virus latent or lytic infection in single human cells utilizing in situ hybridization. Mod Pathol 2004, 17(12):1564572. 9. Hung SC, Kang MS, Kieff E: Upkeep of Epstein-Barr virus (EBV) oriPbased episomes requires EBV-encoded nuclear antigen-1 chromosomebinding domains, which might be replaced by high-mobility group-I or histone H1. Proc Natl Acad Sci U S A 2001, 98(4):1865870. 10. Urlaub G, Chasin LA: Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proc Natl Acad Sci U S A 1980, 77(7):4216220. 11. Derouazi M, Martinet D, Besuchet Schmutz N, Flaction R, Wicht M, Bertschinger M, Hacker DL, Beckmann JS, Wurm FM: Genetic characterization of CHO production host DG44 and derivative recombinant cell lines. Biochem Biophys Res Commun 2006, 340(four):1069077. 12. Weiner M, NK3 Compound Gackstetter T, Costa G, Bauer C, Kretz K: Site-directed Mutagenesis employing PCR. In Molecular Biology: Present Innovations and Future Trends. Edited by Griffin A, Griffin H. Wymondham, Norfolk, U.K: Horizon Scientific Press; 1995. 13. Orlova NA, Orlov AV, Vorobiev II: A modular assembly cloning method (aided by the BIOF application tool) for seamless and error-free assembly of extended DNA fragments. BMC Res Notes 2012, 5:303. 14. Kozak M: An evaluation of 5-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987, 15(20):8125148. 15. Patterson GH, Knobel SM, Sharif WD, Kain SR, Piston DW: Use of the green fluorescent protein and its mutants in quantitative fluorescence microscopy. Biophys J 1997, 73(5):2782790. 16. Ribeiro S, Mairhofer J, Madeira C, Diogo MM, Lobato da Silva C, Monteiro G, Grabherr R, Cabral JM: Plasmid DNA size does affect nonviral gene delivery efficiency in stem cells. Cell Reprogram 2012, 14(2):13037. 17. Wasley LC, Rehemtulla A, Bristol JA, Kaufman RJ: PACE/furin can procedure the vitamin K-dependent pro-factor IX precursor inside the secretory pathway. J Biol Chem 1993, 268(12):8458465.Additional fileAdditional file 1: Primer sequences used for cloning and sequencing the p 1.1 and p 1.2 expression vectors. Abbreviations CHO cells: Chinese hamster ovary (CHO) cells; MTX: Methotrexate; eGFP: Enhanced green fluorescent protein; EBVTR: Concatemer in the terminal repeats from the Epstein-Barr virus; PCR: Polymerase chain reaction; Kbp: Kilo base pairs (1000 base pairs); EEF1A: Chinese hamster Elongation issue 1 alpha; IRES: Internal ribosome entry website; DHFR: dihydrofolate reductase (EC 1.five.1.3); ORF: open reading frame; RFU: relative fluorescence units. Competing interests JAH, AGG and KGS declare that they have no competing interests. NAO, SVK and IIV are inventors from the patent RU2488633, which covers use of the p1.1 vector. Authors’ contribu.